Dougall WC - Search Results

1

RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer.

Behrens A, Wurmthaler L, Heindl F, Gass P, Häberle L, Volz B, Hack CC, Emons J, Erber R, Hartmann A, Beckmann MW, Ruebner M, Dougall WC, Press MF, Fasching PA, Huebner H. Behrens A, et al. Among authors: dougall wc. Geburtshilfe Frauenheilkd. 2023 Nov 22;84(1):77-85. doi: 10.1055/a-2192-2998. eCollection 2024 Jan. Geburtshilfe Frauenheilkd. 2023. PMID: 38178900 Free PMC article.

2

RANK expression on breast cancer cells promotes skeletal metastasis.

Blake ML, Tometsko M, Miller R, Jones JC, Dougall WC. Blake ML, et al. Among authors: dougall wc. Clin Exp Metastasis. 2014 Feb;31(2):233-45. doi: 10.1007/s10585-013-9624-3. Epub 2013 Nov 24. Clin Exp Metastasis. 2014. PMID: 24272640

3

RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.

Armstrong AP, Miller RE, Jones JC, Zhang J, Keller ET, Dougall WC. Armstrong AP, et al. Among authors: dougall wc. Prostate. 2008 Jan 1;68(1):92-104. doi: 10.1002/pros.20678. Prostate. 2008. PMID: 18008334 Free article.

4

Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasis.

Holland PM, Miller R, Jones J, Douangpanya H, Piasecki J, Roudier M, Dougall WC. Holland PM, et al. Among authors: dougall wc. Cancer Biol Ther. 2010 Apr 1;9(7):539-50. doi: 10.4161/cbt.9.7.11266. Epub 2010 Apr 1. Cancer Biol Ther. 2010. PMID: 20150760 Free article.

5

RANK and RANK ligand expression in primary human osteosarcoma.

Branstetter D, Rohrbach K, Huang LY, Soriano R, Tometsko M, Blake M, Jacob AP, Dougall WC. Branstetter D, et al. Among authors: dougall wc. J Bone Oncol. 2015 Jul 29;4(3):59-68. doi: 10.1016/j.jbo.2015.06.002. eCollection 2015 Sep. J Bone Oncol. 2015. PMID: 27556008 Free PMC article.

6

The RANK/RANKL/OPG triad in cancer-induced bone diseases.

Dougall WC, Chaisson M. Dougall WC, et al. Cancer Metastasis Rev. 2006 Dec;25(4):541-9. doi: 10.1007/s10555-006-9021-3. Cancer Metastasis Rev. 2006. PMID: 17180711 Review.

7

Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis.

Canon JR, Roudier M, Bryant R, Morony S, Stolina M, Kostenuik PJ, Dougall WC. Canon JR, et al. Among authors: dougall wc. Clin Exp Metastasis. 2008;25(2):119-29. doi: 10.1007/s10585-007-9127-1. Epub 2007 Dec 5. Clin Exp Metastasis. 2008. PMID: 18064531

8

Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis.

Dougall WC. Dougall WC. Clin Cancer Res. 2012 Jan 15;18(2):326-35. doi: 10.1158/1078-0432.CCR-10-2507. Epub 2011 Oct 26. Clin Cancer Res. 2012. PMID: 22031096

9

[Monoclonal antibody targeting RANKL as a therapy for cancer-induced bone diseases].

Dougall W, Chaisson M. Dougall W, et al. Clin Calcium. 2006 Apr;16(4):627- 35. Clin Calcium. 2006. PMID: 16582514 Review. Japanese.

10

RANKL signaling in bone physiology and cancer.

Dougall WC. Dougall WC. Curr Opin Support Palliat Care. 2007 Dec;1(4):317-22. doi: 10.1097/SPC.0b013e3282f335be. Curr Opin Support Palliat Care. 2007. PMID: 18685382 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters